Robert Alan Beardsley
Board Member
Arbutus Biopharma Corp (ABUS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert Alan Beardsley
Robert Alan Beardsley is recorded as Board Member at Arbutus Biopharma Corp (ABUS). Arbutus Biopharma Corp reported in an 8-K filed May 27, 2026 that Robert Alan Beardsley was appointed director, effective May 26, 2026. Arbutus Biopharma Corp reported in an 8-K filed February 25, 2025 that Robert Alan Beardsley was appointed member of the Board, effective February 24, 2025.
“(1) elected each of the Company’s nominees for director”
“On February 24, 2025, the following individuals were appointed to the Board, effective immediately, to serve until the Company's 2025 annual general meeting of shareholders or until his or her respective successor is duly appointed and qualified, or until his or her earlier death, resignation or removal: ... (ii) Robert Alan Beardsley;”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-26–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arbutus Biopharma Corp
Other people whose current roles at this company are on record from its filings.
- Lindsay Androski CEO, Chairman, Board Member
- Mark J. Murray CEO
- Michael J. McElhaugh CEO, COO, Board Member
- Tuan Nguyen CFO
- Michael McElhaugh COO
- Mike McElhaugh COO
- J. Christopher Naftzger General Counsel
- Anuj Hasija Board Member
- Eric Venker, M.D., Pharm.D. Board Member
- Frank Torti, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.